Cuong Do is the President and CEO of BioVie, a clinical-stage biopharmaceutical company focusing on drug therapies for liver disease.
Cuong Do is the President and CEO of BioVie, a clinical-stage biopharmaceutical company focusing on drug therapies for liver disease, neurodegenerative disorders, and certain cancers. He emphasizes in interviews BioVie's molecule Bezy, which has shown promise in slowing cognitive decline in Alzheimer's trials.
Full founder directory · Investor directory · Company funding database · Fundraising library